Assessment of novel tobacco heating product THP1.0. Part 7: Comparative in vitro toxicological evaluation

Regulatory Toxicology and Pharmacology

Volumn 93, Issue , 2018, Pages 71-83

  Thorne, David ^a   Breheny, Damien ^a   Proctor, Christopher ^a   Gaca, Marianna ^a  

^a BRITISH AMERICAN TOBACCO   (United Kingdom)

Author keywords

Ames; Bhas transformation assay; In vitro; Mouse lymphoma; Neutral red uptake; Tobacco heating products; TPM; Whole aerosol

Indexed keywords

CIGARETTE SMOKE; TOBACCO HEATING PRODUCT THP1.0; TOBACCO SMOKE; UNCLASSIFIED DRUG; MUTAGENIC AGENT;

AEROSOL; ANIMAL CELL; ARTICLE; CARCINOGENICITY; CIGARETTE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; HEATING; IN VITRO STUDY; MOUSE; MUTAGENICITY; NONHUMAN; PARTICULATE MATTER; PRIORITY JOURNAL; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; TOBACCO; TOXICOLOGY; ANALYSIS; ANIMAL; BAGG ALBINO MOUSE; BALB/3T3 CELL LINE; CELL SURVIVAL; DRUG EFFECT; ELECTRONIC CIGARETTE; GENETICS; MUTAGEN TESTING; PHYSIOLOGY; PROCEDURES; RAT; TOXICITY; TOXICITY TESTING; TUMOR CELL LINE;

AEROSOLS; ANIMALS; BALB 3T3 CELLS; CELL LINE, TUMOR; CELL SURVIVAL; ELECTRONIC NICOTINE DELIVERY SYSTEMS; HEATING; MICE; MICE, INBRED BALB C; MUTAGENICITY TESTS; MUTAGENS; RATS; SALMONELLA TYPHIMURIUM; TOXICITY TESTS;

EID: 85033499995     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2017.08.017     Document Type: Article

References (60)

1. Adamson, J., Thorne, D., Errington, G., Fields, W., Li, X., Payne, R., Krebs, T., Dalrymple, A., Fowler, K., Dillon, D., Xie, F., Meredith, C., An inter-machine comparison of tobacco smoke particle deposition in vitro from six independent smoke exposure systems. Toxicol. Vitro 28 (2014), 1320–1328.
2. Adamson, J., Thorne, D., Zainuddin, B., Baxter, A., McAughey, J., Gaça, M., Application of dosimetry tools for the assessment of e-cigarette aerosol and cigarette smoke generated on two different in vitro exposure systems. Chem. Central J., 10, 2016, 74.
3. Andreoli, C., Gigante, D., Nunziata, A., A review of in vitro methods to assess the biological activity of tobacco smoke with the aim of reducing the toxicology of smoke. Toxicol. Vitro 17 (2003), 587–594.
4. Azzopardi, D., Patel, K., Jaunky, T., Santopietro, S., Camacho, O.M., McAughey, J., Gaca, M., Electronic cigarette aerosol induces significantly less cytotoxicity than tobacco smoke. Toxicol. Mech. Meth. 26 (2016), 477–491.
5. Baker, R.R., Smoke generation inside a burning cigarette: modifying combustion to develop cigarettes that may be less hazardous to health. Prog. Energy Combust. Sci. 32:4 (2006), 373–385.
6. Bombick, D., Bombick, B., Ayres, P., Putnam, K., Avalos, J., Evaluation of the genotoxic and cytotoxic potential of mainstream whole smoke and smoke condensate from a cigarette containing a novel carbon filter. Fundam. Appl. Toxicol. 39 (1997), 11–17.
7. Branton, P., McAdam, K., Winter, D., Liu, C., Duke, M., Proctor, C., Reduction of aldehydes and hydrogen cyanide yields in mainstream cigarette smoke using an amine functionalised ion exchange resin. Chem. Central J., 5, 2011, 15.
8. Breheny, D., Cunningham, F., Kilford, J., Payne, R., Dillon, D., Meredith, C., Application of a modified gaseous exposure system to the in vitro toxicological assessment of tobacco smoke toxicants. Environ. Mol. Mutagen. 55:8 (2014), 662–672.
9. Breheny, D., Oke, O., Pant, K., Gaca, M., Comparative tumour promoting assessment of e-cigarettes and cigarettes using the in vitro Bhas 42 cell transformation assay. Environ. Mol. Mutagen. 58 (2017), 190–198.
10. Breheny, D., Chuan, L., Adamson, J., Azzopardi, D., Baxter, A., Bishop, E., Carr, T., Crooks, I., Hewitt, K., Jaunky, T., Larard, S., Lowe, F., Oke, T., Taylor, M., Santopietro, S., Thorne, D., Zainuddin, B., Gaca, M., Murphy, J., Proctor, C., A novel hybrid product that heats tobacco through controlled aerosol release (Part 2): in vitro biological assessment and comparison with different tobacco-heating products. Food Chem. Toxicol. 106 (2017), 533–546.
11. COM, Guidance on a Strategy for Genotoxicity Testing of Chemical Substances. 2011 https://cot.food.gov.uk/sites/default/files/cot/cotcomcocreport2011.pdf. (Accessed 23 March 2017)
12. Combes, R., Scott, K., Dillon, D., Meredith, C., McAdam, K., Proctor, C., The effect of a novel tobacco process on the in vitro cytotoxicity and genotoxicity of cigarette smoke particulate matter. Toxicol. Vitro 360:6 (2012), 1022–1029.
13. Combes, R., Scott, K., Crooks, I., Dillon, D., Meredith, C., McAdam, K., Proctor, C., The in vitro cytotoxicity and genotoxicity of cigarette smoke particulate matter with reduced toxicant yields. Toxicol. Vitro 27:5 (2013), 1533–1541.
14. CORESTA, The Rationale and Strategy for Conducting in Vitro Toxicological Testing of Tobacco Smoke. 2004 https://www.coresta.org/rationale-and-strategy-conducting-vitro-toxicology-testing-tobacco-smoke-29237.html. (Accessed 23 March 2017)
15. Crooks, I., Dillon, D., Scott, K., Ballantyne, M., Meredith, C., The effect of long term storage on tobacco smoke particulate matter in in vitro genotoxicity and cytotoxicity assays. Regul. Toxicol. Pharmacol. 65:2 (2013), 196–200.
16. De Serres, F., Shelby, M., Recommendations on data production and analysis using the Salmonella/microsome mutagenicity assay. Mutat. Res. 64 (1979), 159–165.
17. Dittrich, D., Fieblekorn, R., Bevan, M., Rushford, D., Murphy, J., Ashley, M., McAdam, K., Liu, C., Proctor, C., Approaches for the design of reduced toxicant emission cigarettes. SpringerPlus, 3, 2014, 374.
18. Doolittle, D., Lee, C., Ivett, J., Mirsalis, J., Riccio, E., Ruud, C., Burger, G., Hayes, W., Comparative studies on the genotoxic activity of mainstream smoke condensate from cigarettes which burn or only heat tobacco. Environ. Mol. Mutagen. 15 (1990), 93–105.
19. Eaton, D., Jakaj, B., Forster, M., Nicol, J., Mavropoulou, E., Scott, J.K., Liu, C., McAdam, K.G., Murphy, J., Proctor, C.J., Assessment of tobacco heating product THP1.0. Part 2: product design, operation and thermophysical characterisation. Regul. Toxicol. Pharmacol., 2017 (in this issue).
20. Forster, M., Fiebelkorn, S., Yurteri, C., Mariner, C., Liu, C., Wright, C., McAdam, K., Murphy, J., Proctor, C., Assessment of tobacco heating product THP1.0. Part 3: comprehensive chemical characterisation - harmful and potentially harmful aerosol emissions. Regul. Toxicol. Pharmacol., 2017 (in this issue).
21. Foy, D., Bombick, B., Bombick, D., Doolittle, D., Mosberg, A., Swauger, J., A comparison of in vitro toxicities of cigarette smoke condensate from Eclipse cigarettes and four commercially available ultra low-“tar” cigarettes. Food Chem. Toxicol. 42 (2004), 237–243.
22. Goniewicz, M., Knysak, J., Gawron, M., Kosmider, L., Sobczak, A., Kurek, J., Prokopowicz, A., Jablonska-Czapla, M., Rosik-Dulewska, C., Havel, C., Jacob, P., Benowitz, N., Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob. Control 23 (2014), 133–139.
23. Health Canada Official Method T-115, Determination of “Tar” Nicotine and Carbon Monoxide in Mainstream Tobacco Smoke. Dec 1999.
24. Health Canada, Regulations amending the tobacco reporting regulations. http://www.hc-sc.gc.ca/hc-ps/tobac-tabac/legislation/reg/indust/method/tox-eng.php, 2005. (Accessed 23 March 2017)
25. −/− mouse lymphoma mutagenesis assay system. Mutat. Res. 84 (1981), 169–181.
26. ICH-S2R1, Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use. 2011 http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-ld/ich/securit/s2r1-step4etape-eng.php. (Accessed 23 March 2017)
27. Institute of Medicine, Scientific Standards for Studies on Modified Risk Tobacco Products. 2011, National Academies Press, Washington, DC.
28. Ishikawa, S., Kanermaru, Y., Nara, H., Erami, K., Nagata, Y., Assessing the mutagenic activities of smoke from different cigarettes in direct exposure experiments using the modified Ames Salmonella assay. Mutat. Res. 803-804 (2016), 13–21.
29. ISO, 1999. ISO, Tobacco and tobacco products. Atmos. Cond. Test., 1999 ISO 3402:1999 http://www.iso.org/iso/iso_catalogue/catalogue_tc/catalogue_detail.htm?csnumber=28324. (Accessed 23 March 2017)
30. Kilford, J., Thorne, D., Payne, R., Dalrymple, A., Clements, J., Meredith, C., Dillon, D., A method for assessment of the genotoxicity of mainstream cigarette-smoke by use of the bacterial reverse-mutation assay and an aerosol-based exposure system. Mutat. Res. 769 (2014), 20–28.
31. Lewis, R., Jack, A., Morris, J., Robert, V., Gavilano, L., Siminszky, B., Bush, L., Hayes, A., Dewey, R., RNA interference (RNAi)induced suppression of nicotine demethylase activity reduces levels of a key carcinogen in cured tobacco leaves. Plant Biotechnol. J. 6 (2008), 346–354.
32. Liu, C., DeGrandpre, Y., Porter, A., Griffiths, A., McAdam, K., Voisine, R., Cote, F., Proctor, C., The use of a novel treatment process to reduce toxicant yields in cigarette smoke. Food Chem. Toxicol. 49 (2011), 1904–1917.
33. ® 24/48 in vitro aerosol exposure system using mainstream cigarette smoke. Chem. Central J., 8, 2014, 62.
34. Maron, D., Ames, B., Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113 (1983), 173–215.
35. McAdam, K., Gregg, E., Liu, C., Dittrich, D., Duke, M., Proctor, C., The use of a novel tobacco substitute sheet and smoke dilution to reduce toxicant yields in cigarette smoke. Food Chem. Toxicol. 49 (2001), 1684–1696.
36. Murphy, J., Gaca, M., Lowe, F., Minet, E., Fiebelkorn, S., Prasad, K., Camacho, O., Fearon, I., Liu, C., Wright, C., McAdam, K., Proctor, C., A modified risk tobacco and nicotine product assessment framework and the demonstration of a closed modular electronic cigarette as a potentially reduced risk product. Submitt. Regul. Toxicol. Pharmacol., 2017 (in this issue).
37. OECD, Test No 471: Bacterial Reverse Mutation Test, OECD Guideline for the Testing of Chemicals. Test Guideline 471, 1997 http://www.oecd-ilibrary.org/environment/test-no-471-bacterial-reverse-mutation-test_9789264071247-en.
38. OECD, Test No. 490: in Vitro Mammalian Cell Gene Mutation Tests Using the Thymidine Kinase Gene. Test Guideline 490, 2015 http://www.oecd-ilibrary.org/environment/test-no-490-in-vitro-mammalian-cell-gene-mutation-tests-using-the-thymidine-kinase-gene_9789264242241-en.
39. OECD, Test No 231: Guidance Document on the in Vitro Bhas 42 Cell Transformation Assay. Test no: 231. Series on Testing and Assessment. No. 231. Paris. 2016, 2016 https://www.oecd.org/env/ehs/testing/ENV_JM_MONO(2016)1.pdf.
40. Parry, E.M., Parry, J.M., Corso, C., Doherty, A., Haddad, F., Hermine, T.F., Johnson, G., Kayani, M., Quick, E., Warr, T., Williamson, J., Detection and characterization of mechanisms of action of aneugenic chemicals. Mutagenesis 17 (2002), 509–521.
41. Piadé J., Wajrock, S., Jaccard, G., Janeke, G., Formation of mainstream cigarette smoke constituents prioritized by the World Health Organization – yield patterns observed in market surveys, clustering and inverse correlations. Food Chem. Toxicol. 55 (2013), 329–347.
42. Polat, S., Apaydin-Varol, E., Pütün, A., Thermal decomposition behavior of tobacco stem Part I: TGA–FTIR–MS analysis. Energy sources. Part A 38:20 (2016), 3065–3072.
43. Polat, S., Apaydin-Varol, E., Pütün, A., Thermal decomposition behavior of tobacco stem Part II: kinetic analysis. Energy sources. Part A, 38(20), 2016 3073–3072.
44. R.J. Reynolds Tobacco Company, Chemical and Biological Studies: New Cigarette Prototype that Heat Instead of Burn Tobacco. 1988, R.J. Reynolds Tobacco Co, Winston-Salem, NC.
45. Rodgman, A., Green, R., Toxic chemicals in cigarette mainstream smoke - hazard and hoopla. Beiträge zur Tab. Int. 20:8 (2014), 481–545.
46. Roemer, E., Schramke, H., Weiler, H., Buettner, A., Kausche, S., Weber, S., Berges, A., Stueber, M., Muench, M., Trelles-Sticken, E., Pype, J., Kohlgrueber, K., Voelkel, H., Wittke, S., Mainstream smoke chemistry and in vitro and in vivo toxicity of the reference cigarettes 3R4F and 2R4F. Beiträge zur Tab. Int. 25 (2012), 316–335.
47. Schaller, J.P., Keller, D., Poget, L., Pratte, P., Kaelin, E., McHugh, D., Cudazzo, G., Smart, D., Tricker, A.R., Gautier, L., Yerly, M., Pires, R.R., Le Bouhellec, S., Ghosh, D., Hofer, I., Garcia, E., Vanscheeuwijck, P., Maeder, S., Evaluation of the Tobacco Heating System 2.2. Part 2: chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol. Regul. Toxicol. Pharmacol., 81, 2016, S27eS47.
48. Scott, K., Saul, J., Crooks, I., Camacho, O., Dillon, D., Meredith, C., The resolving power of in vitro genotoxicity assays for cigarette smoke particulate matter. Toxicol. Vitro 27 (2013), 1312–1319.
49. Smith, C., McKams, S., Davis, R., Livingston, S., Bombick, B., Avalos, J., Morgan, W., Doolittle, D., Human urine mutagenicity study comparing cigarettes which burn or primarily heat tobacco. Mutat. Res. Environ. Mutagen. 361 (1996), 1–9.
50. Smith, M.R., Clark, B., Luedicke, F., Schaller, J.P., Vanscheeuwijck, P., Hoeng, J., Peitsch, M.C., Evaluation of the tobacco heating system 2.2. Part 1: description of the system and the scientific assessment program. Regul. Toxicol. Pharmacol., 81, 2016, S17eS26.
51. Stratton, K., Shetty, P., Wallace, R., Clearing the smoke: assessing the science base for tobacco harm reduction. Institute of Medicine, 2001, National Academies Press, Washington, DC.
52. The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM), Test Method Protocol for the BALB/c 3T3 NRU Cytotoxicity Test Method, Appendix C1. NIH publication No. 07–4519. November, 2006 https://ntp.niehs.nih.gov/pubhealth/evalatm/test-method-evaluations/acute-systemic-tox/in-vitro-validation/tmer/index.html.
53. Thorne, D., Adamson, J., A review of in vitro exposure systems. Exp. Toxicol. Pathol. 65 (2013), 1183–1193.
54. ® VC 10 in vitro smoke exposure system using dose tools and biological analysis. Chem. Central J., 7, 2013, 146.
55. Thorne, D., Kilford, J., Hollings, M., Dalrymple, A., Ballantyne, M., Meredith, C., Dillon, D., The mutagenic assessment of mainstream cigarette smoke using the Ames assay: a multi-strain approach. Mutat. Res. 782 (2015), 9–17.
56. Thorne, D., Crooks, I., Hollings, M., Seymour, A., Meredith, C., Gaça, M., The mutagenic assessment of an electronic-cigarette and cigarette smoke using the Ames assay in strains TA98 and TA100. Mutat. Res. 812 (2016), 29–38.
57. US Department of Health and Human Services, The Health Consequences of Smoking 50 Years of Progress: a Report of the Surgeon General, 2014. Atlanta, USA, 2014 http://www.surgeongeneral.gov/library/reports/50-years-of-progress/index.html. (Accessed 23 March 2017)
58. Várhegyi, G., Czégény, Z., Liu, C., McAdam, K., Thermogravimetric analysis of tobacco combustion assuming DAEM devolatilization and empirical char-burnoff kinetics. Ind. Eng. Chem. Res. 49 (2010), 1591–1599.
59. Weisensee, D., Poth, A., Roemer, E., Conroy, L.L., Schlage, W.K., Cigarette smoke-induced morphological transformation of Bhas 42 cells in vitro. Altern. Laboratory Animals 41 (2013), 181–189.
60. Xiang, L., Cong, N., Pingping, S., Fuwei, X., Huimin, L., Jianping, X., Evaluation method for the cytotoxicity of cigarette smoke by in vitro whole smoke exposure. Exp. Toxicol. Pathology 66:1 (2014), 27–33.